Sho Miyamoto

Title: Sho Miyamoto: Innovator in Cancer Research

Introduction

Sho Miyamoto is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of innovative detection agents and therapeutic compositions.

Latest Patents

Miyamoto holds a patent for a tumor antigen peptide. The purpose of this invention is to provide a detection agent for specifically identifying cancer stem cells. It includes a tumor antigen peptide that is specifically presented by these cells, along with a medicinal composition useful in preventing and treating cancer. This composition comprises the tumor antigen peptide as an active ingredient. The invention also outlines a method for screening the tumor antigen peptide and provides peptides represented by Y-X-Z, a polyepitope peptide consisting of multiple epitope peptides, and a polynucleotide encoding these peptides. The medicinal composition aims to induce cytotoxic T lymphocytes (CTL) for cancer treatment.

Career Highlights

Miyamoto has worked with notable institutions, including Sapporo Medical University and Sumitomo Dainippon Pharma Co., Ltd. His work has focused on advancing cancer treatment methodologies and improving detection techniques.

Collaborations

Some of his notable coworkers include Noriyuki Sato and Toshihiko Torigoe. Their collaborative efforts have contributed to the advancements in cancer research and therapeutic development.

Conclusion

Sho Miyamoto is a dedicated inventor whose work in cancer research has the potential to significantly impact the field. His innovative approaches to detecting and treating cancer stem cells highlight the importance of continued research and development in this critical area.